Sofalcone, a gastroprotective drug, covalently binds to KEAP1 to activate Nrf2 resulting in anti-colitic activity.

MLA

Kim, Wooseong, et al. “Sofalcone, a Gastroprotective Drug, Covalently Binds to KEAP1 to Activate Nrf2 Resulting in Anti-Colitic Activity.” European Journal of Pharmacology, vol. 865, Dec. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejphar.2019.172722.

APA

Kim, W., Lee, H., Kim, S., Joo, S., Jeong, S., Yoo, J.-W., & Jung, Y. (2019). Sofalcone, a gastroprotective drug, covalently binds to KEAP1 to activate Nrf2 resulting in anti-colitic activity. European Journal of Pharmacology, 865, N.PAG. https://doi.org/10.1016/j.ejphar.2019.172722

Chicago

Kim, Wooseong, Hanju Lee, Soojin Kim, Sanghyun Joo, Seongkeun Jeong, Jin-Wook Yoo, and Yunjin Jung. 2019. “Sofalcone, a Gastroprotective Drug, Covalently Binds to KEAP1 to Activate Nrf2 Resulting in Anti-Colitic Activity.” European Journal of Pharmacology 865 (December): N.PAG. doi:10.1016/j.ejphar.2019.172722.